The Georgetown University Memory Disorders Program is dedicated to providing state-of-the-art clinical services for individuals affected by Alzheimer's disease and related disorders and to conducting research aimed at improving treatment options for Alzheimer's disease.
WE ARE ON FACEBOOK
"Like" our facebook page to stay up to date on research findings and helpful information
BE A PART OF OUR NEWSLETTER!
Would you like to write an article for our Spring newsletter? Sign up here to share your experiences with the MDP or to address any issues relevant to those we serve. If you are not interested in composing an article, you are welcome to list topics you would like to see discussed in our next newsletter. Click this link for more.
Here are our research studies that are currently recruiting patients.
|Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss (A4)||ADCS/ Eli Lilly and Company|
Eli Lilly and Company
|ADCS/Toyama Chemical Co.|
Check out our Research section for more information on how to participate in our clinical trials.
Make a Donation
For information about how to make a tax-deductible contribution to the Memory Disorders Program, please click here.